SavedAdd your journal

Journals / MN Kardiyoloji / 2000 / Cilt: 7 - Sayı: 4

A case with right side implant of the implantable cardioverter-defibrillator system and review of the literature

Sağ pektoral bölgeye takılabilir kardioverter defibrilatör (ICD) implantasyonu yapılan olgunun sunusu ve konuyla ilgili literatür araştırması

Oben DÖVEN
Muharrem GÜLDAL
Remzi KARAOĞUZ
Derviş ORAL
Pages
316–319
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We did not observed any problem with new device on the right side and defibrillation threshold was good enough to provide a safety margin of at least 10 Joule.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Implantable cardioverter-defibrillator is the dominant therapeutic modality for patients with life threatening ventricular arrhythmia's.
📊
Key Findings & Data:They have high-energy shocks, antitachycardia and as well as antibradycardia pacing properties.
💡
Conclusion & Impact:We did not observed any problem with new device on the right side and defibrillation threshold was good enough to provide a safety margin of at least 10 Joule.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Erişkin · Erkek · Elektrokardiyografi

Abstract

Implantable cardioverter-defibrillator is the dominant therapeutic modality for patients with life threatening ventricular arrhythmia's. They have high-energy shocks, antitachycardia and as well as antibradycardia pacing properties. Complications including lead extraction have been described by many physicians since newly developed transvenous electrode systems were used. We may extrapolate the pacemaker lead removal to ICD lead extraction, however ICD leads exhibits specificity's related to their particular design and large diameter. We report the case with ventricular tachycardia who requires lead removal due to the insulation defect. The patient underwent total removal of the defibrillator system and reimplantation was performed on the right pectoral region due to the left subclavian vein stenosis documented with prior subclavian vein catheterization. We did not observed any problem with new device on the right side and defibrillation threshold was good enough to provide a safety margin of at least 10 Joule.

Özet

Takılabilir kardiyoverter defibrilatörler (ICD) günümüzde hayatı tehdit eden ventriküler aritmilerin tedavisinde önemli bir yöntem olarak yerini almıştır. İCD' ler yüksek şok enerjisine sahip, antitaşikardik ve antibradikardik uyarı özellikleri bulunan cihazlardır. Gelişen teknolojiyle kullanıma giren yeni transvenöz elektrod sistemleri ekstraksiyona kadar giden yeni komplikasyonları gündeme getirmiştir. ICD elektrotlarının ekstraksiyonu "pacemaker" elektrotu ekstraksiyonuna benzerlik göstermesine rağmen özel yapısı ve geniş çapından dolayı birtakım farklılıklar gösterir. Elektrottaki insülasyon bozukluğundan dolayı sistemi değiştirilen ventriküler taşikardili olgumuzda eski elektrota bağlı olarak gelişen sol subklavian ven darlığı sonucunda yeni sistem sağ pektoral bölgeye takıldı. Sağ pektoral adele içine yerleştirilen sistemle yeterli defibrilasyon eşiği sağlanabildi ve 10 J'lük emniyet sınırı bırakıldı.

🔖

Cite This Article

DÖVEN, O., GÜLDAL, M., KARAOĞUZ, R., ORAL, D. (2000). A case with right side implant of the implantable cardioverter-defibrillator system and review of the literature. MN Kardiyoloji, Cilt: 7 - Sayı: 4, 316–319. https://ajindex.com/articles/298093

References (2)

  1. Echt D, Armstrong K, Schmidt P, Oyers PE, Stinson EB, Winkle RA. Clinical experience, complications, and survival in 70 patients with automatic implantable cardioverter defibrillator. Circulation 19885; 71:289. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990; 16:381. Lehmann MH, Steinman RT, Schuger C, Jackson K. The automatic implantable cardioverter-defibrillator as antiarrhytmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol 1988;62:803. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, et al. Long term outcome with automatic implantable cardioverter- defibrillator. J Am Coll Cardiol. 1989; 13:1353. Yee R, Klein GJ, Leitch JW, et al. A permanent transvenous lead system for an implantable pacemaker cardioverter- defibrillatornontoracotomy approach to implantation. Circulation 1992; 85:196. Bardy GH, Hofer B, Johnson G, et al. Implantable transvenous cardioverter-defibrillators. Circulation 1993;87:1152. Pinski SL, Fahy G. Implantable cardioverter-defibrillators. Am J Med. 1999; 106:446. O'Nunain S, Perez I, Roelke M, et al. The treatment of patients with infected implantable cardioverter-defibrillator system. J Thorac Cardiovasc Surg 1997;113:121. Kennerğen C. Impact of implant techniques on complications with current implantable defibrillation systems. Am J Cardiol 1996; 78(5): 15. Watkins L, Taylor E. The surgical aspects of automatic implantable cardioverter-defibrillator implantation. PACE 1991;14:953. McCowan R, Maloney J, Wilkoff B, et al. Automatic implantable cardioverter-defibrillator implantation without thoracotomy using an endocardial and submuscular patch system. J Am Coll Cardiol.1991;17:415. Smith H, Feamot N, Byrd C, Wilkoff B, Love C, Sellers D. Five years experience with intravascular lead extraction.Pace 1994;17:2016.
  2. Franc PL, Klug D, Jarwe M. Extraction of endocardial implantable cardioverter-defibrillator leads. Am J Cardiol 1999;84:187. Jarve M, Klug D, Franc P, Lacroix D, Koukam C, Kacet S. Pacemaker lead extraction: comparision of lead removal via the implantation vein or via the femoral vein. Circulation 1998;98(1):1- 426. Tullo NG.Saksena S, Krol RB, Mauro AM, Kunecz D. Management of complications associated with a first generation endocardial defibrillation lead system for implantabl